SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-037719
Filing Date
2020-08-06
Accepted
2020-08-06 16:05:57
Documents
20
Period of Report
2020-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20200806.htm   iXBRL 8-K 35215
2 EX-99.1 sndx-ex991_6.htm EX-99.1 230188
3 GRAPHIC gqmo3qfatch4000006.jpg GRAPHIC 2883
4 GRAPHIC gqmo3qfatch4000004.jpg GRAPHIC 2883
5 GRAPHIC gqmo3qfatch4000002.jpg GRAPHIC 2883
6 GRAPHIC gqmo3qfatch4000005.jpg GRAPHIC 2883
7 GRAPHIC gqmo3qfatch4000007.jpg GRAPHIC 2883
8 GRAPHIC gqmo3qfatch4000001.jpg GRAPHIC 2883
9 GRAPHIC gqmo3qfatch4000003.jpg GRAPHIC 2883
  Complete submission text file 0001564590-20-037719.txt   445980

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA sndx-20200806.xsd EX-101.SCH 5768
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20200806_lab.xml EX-101.LAB 20990
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20200806_pre.xml EX-101.PRE 12535
13 EXTRACTED XBRL INSTANCE DOCUMENT sndx-8k_20200806_htm.xml XML 3792
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 201081559
SIC: 2834 Pharmaceutical Preparations